Cargando…

The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity

INTRODUCTION: One in three US adults is living with obesity or hypertension, and more than 75% of hypertensive individuals are using antihypertensive medications. Therefore, it is important to examine blood pressure (BP) differences in populations that are using these medications with differing obes...

Descripción completa

Detalles Bibliográficos
Autores principales: Parikh, Jash S., Randhawa, Arshdeep K., Wharton, Sean, Edgell, Heather, Kuk, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188586/
https://www.ncbi.nlm.nih.gov/pubmed/30364090
http://dx.doi.org/10.1155/2018/4573258
_version_ 1783363208946384896
author Parikh, Jash S.
Randhawa, Arshdeep K.
Wharton, Sean
Edgell, Heather
Kuk, Jennifer L.
author_facet Parikh, Jash S.
Randhawa, Arshdeep K.
Wharton, Sean
Edgell, Heather
Kuk, Jennifer L.
author_sort Parikh, Jash S.
collection PubMed
description INTRODUCTION: One in three US adults is living with obesity or hypertension, and more than 75% of hypertensive individuals are using antihypertensive medications. Therefore, it is important to examine blood pressure (BP) differences in populations that are using these medications with differing obesity status. AIM: We examined whether BP attained when using various antihypertensive medications varies amongst different body mass index (BMI) categories and whether antihypertensive medication use is associated with differences in other metabolic risk factors, independent of BMI. METHODS: Adults with hypertension from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2014 were used (n=15,285). Linear regression analyses were used to examine the main effects and interaction between antihypertensive use and BMI. RESULTS: In general, users of antihypertensive medications had lower BP than those not taking BP medications (NoBPMed) (P < 0.05), whereby in women, the differences in systolic BP between angiotensin-converting-enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) users and NoBPMed were greater in those with obesity (ACE inhibitors: −14 ± 1 mmHg; ARB: −16 ± 1 mmHg) compared to normal weight individuals (ACE inhibitors: −9 ± 1 mmHg; ARB: −11 ± 1 mmHg) (P < 0.05). Diastolic BP differences between women ARB users and NoBPMed were also greatest in obesity (−5 ± 1 mmHg) (P < 0.05) whilst there were no differences in normal weight individuals (−1 ± 1 mmHg) (P>0.05). Furthermore, glucose levels and waist circumference in women were higher in those using ACE inhibitors compared to diuretics (P < 0.05). CONCLUSION: ACE inhibitors and ARBs may be associated with more beneficial BP profiles in women with obesity, with no obesity-related BP differences for antihypertensive medication in men. However, there could be potential cardiometabolic effects for some antihypertensive medications that should be explored further.
format Online
Article
Text
id pubmed-6188586
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-61885862018-10-25 The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity Parikh, Jash S. Randhawa, Arshdeep K. Wharton, Sean Edgell, Heather Kuk, Jennifer L. J Obes Research Article INTRODUCTION: One in three US adults is living with obesity or hypertension, and more than 75% of hypertensive individuals are using antihypertensive medications. Therefore, it is important to examine blood pressure (BP) differences in populations that are using these medications with differing obesity status. AIM: We examined whether BP attained when using various antihypertensive medications varies amongst different body mass index (BMI) categories and whether antihypertensive medication use is associated with differences in other metabolic risk factors, independent of BMI. METHODS: Adults with hypertension from the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2014 were used (n=15,285). Linear regression analyses were used to examine the main effects and interaction between antihypertensive use and BMI. RESULTS: In general, users of antihypertensive medications had lower BP than those not taking BP medications (NoBPMed) (P < 0.05), whereby in women, the differences in systolic BP between angiotensin-converting-enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) users and NoBPMed were greater in those with obesity (ACE inhibitors: −14 ± 1 mmHg; ARB: −16 ± 1 mmHg) compared to normal weight individuals (ACE inhibitors: −9 ± 1 mmHg; ARB: −11 ± 1 mmHg) (P < 0.05). Diastolic BP differences between women ARB users and NoBPMed were also greatest in obesity (−5 ± 1 mmHg) (P < 0.05) whilst there were no differences in normal weight individuals (−1 ± 1 mmHg) (P>0.05). Furthermore, glucose levels and waist circumference in women were higher in those using ACE inhibitors compared to diuretics (P < 0.05). CONCLUSION: ACE inhibitors and ARBs may be associated with more beneficial BP profiles in women with obesity, with no obesity-related BP differences for antihypertensive medication in men. However, there could be potential cardiometabolic effects for some antihypertensive medications that should be explored further. Hindawi 2018-10-01 /pmc/articles/PMC6188586/ /pubmed/30364090 http://dx.doi.org/10.1155/2018/4573258 Text en Copyright © 2018 Jash S. Parikh et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Parikh, Jash S.
Randhawa, Arshdeep K.
Wharton, Sean
Edgell, Heather
Kuk, Jennifer L.
The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity
title The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity
title_full The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity
title_fullStr The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity
title_full_unstemmed The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity
title_short The Association between Antihypertensive Medication Use and Blood Pressure Is Influenced by Obesity
title_sort association between antihypertensive medication use and blood pressure is influenced by obesity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188586/
https://www.ncbi.nlm.nih.gov/pubmed/30364090
http://dx.doi.org/10.1155/2018/4573258
work_keys_str_mv AT parikhjashs theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT randhawaarshdeepk theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT whartonsean theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT edgellheather theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT kukjenniferl theassociationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT parikhjashs associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT randhawaarshdeepk associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT whartonsean associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT edgellheather associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity
AT kukjenniferl associationbetweenantihypertensivemedicationuseandbloodpressureisinfluencedbyobesity